Is it cost-effective to request IgM oligoclonal bands against lipids in daily practice as a biomarker for poor prognosis in multiple sclerosis?
| Autor: | Ribes García, Sara, Castillo-Villalba, Jessica, Gasque Rubio, Raquel, Carratalà Boscà, Sara, Cubas-Nuñez, Laura, Alcalá, Carmen, Pérez-Miralles, Francisco Carlos, Bonaventura, Casanova Estruch |
|---|---|
| Zdroj: | In Multiple Sclerosis and Related Disorders November 2023 79 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect